Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 27;20(1):57.
doi: 10.1186/s12957-022-02493-6.

A comprehensive analysis of renal cell carcinoma as first and second primary cancers

Affiliations

A comprehensive analysis of renal cell carcinoma as first and second primary cancers

Jinchao Chen et al. World J Surg Oncol. .

Abstract

Objective: Second primary renal cell carcinoma (2nd RCC) refers to renal cell carcinoma (RCC) diagnosed after another unrelated malignancy. This study aims to compare the clinical manifestation, pathology, treatment, and prognostic features of patients with 2nd RCC and first primary renal cell carcinoma (1st RCC).

Materials and methods: Data of the patients with localized RCC were retrospectively collected. They were classified as 2nd RCC or 1st RCC according to a previously diagnosed cancer, including 113 cases of 2nd RCC and 749 cases of 1st RCC.

Results: The most common types of extrarenal malignancies in patients with 2nd RCC include lung, colorectal, breast, gynecological, and gastric cancers. The age and smoking rate of 2nd RCC patients were significantly higher than in those of 1st RCC patients. For 2nd RCC patients, fewer had clinical symptoms and renal masses tend to be smaller. One hundred and eight (95.6%) patients with 2nd RCC received surgical interventions. All patients with 1st RCC underwent renal surgery. More patients with 2nd RCC underwent a partial nephrectomy. Pathologically, there was no significant difference in postoperative pathological types between the 2nd and 1st RCCs. However, the 2nd RCCs were commonly identified in the early stages. The median overall survival (OS) of 2nd RCC patients was 117 months, which was shorter than that of 1st RCC patients.

Conclusions: Second RCC is not uncommon. More attention should be paid to screening for 2nd RCC in cancer survivors. There are some differences between patients with 2nd and 1st RCCs that should be viewed separately.

Keywords: Comparison; Multiple primary malignancy; Renal cell carcinoma; Second primary cancers.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Kaplan-Meier curves for progression-free survival (PFS) (A), cancer-specific survival (CSS) (B), and overall survival (OS) (C) in patients with second primary renal cell carcinoma (2nd RCC) and first primary renal cell carcinoma (1st RCC)

Similar articles

Cited by

References

    1. Rabbani F, Grimaldi G, Russo P. Multiple primary malignancies in renal cell carcinoma. J Urol. 1998;160(4):1255–1259. doi: 10.1016/S0022-5347(01)62510-2. - DOI - PubMed
    1. Jo JH, Cho IR, Jung JH, Lee HS, Chung MJ, Bang S, Park SW, Chung JB, Song SY, Park JY. Clinical characteristics of second primary pancreatic cancer. PLoS One. 2017;12(6):e0179784. doi: 10.1371/journal.pone.0179784. - DOI - PMC - PubMed
    1. Liu H, Hemminki K, Sundquist J, Holleczek B, Katalinic A, Emrich K, Jansen L, Brenner H. GEKID Cancer Survival Working Group. A population-based comparison of second primary cancers in Germany and Sweden between 1997 and 2006: clinical implications and etiologic aspects. Cancer Med. 2013;2(5):718–724. doi: 10.1002/cam4.116. - DOI - PMC - PubMed
    1. Donin N, Filson C, Drakaki A, Tan HJ, Castillo A, Kwan L, Litwin M, Chamie K. Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008. Cancer. 2016;122(19):3075–3086. doi: 10.1002/cncr.30164. - DOI - PMC - PubMed
    1. Dong C, Hemminki K. Second primary neoplasms in 633,964 cancer patients in Sweden, 1958-1996. Int J Cancer. 2001;93(2):155–161. doi: 10.1002/ijc.1317. - DOI - PubMed